Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma

Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.

Detalles Bibliográficos
Autores principales: Reza‐Albarrán, Alfredo Adolfo, Andino Ríos, Gerson Geovany, Gómez Herrera, Laura Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930188/
https://www.ncbi.nlm.nih.gov/pubmed/29744071
http://dx.doi.org/10.1002/ccr3.1478
Descripción
Sumario:Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.

Ejemplares similares